CATX vs DASH · rev $2.2M vs P/E 76, rev $13.72B
Perspective Therapeutics Inc. (CATX) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
CATX currently screens at market cap $280.6M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the CATX and DASH stock pages for the full models.
Not investment advice.